JAG2 and ovarian cancer: The results taken together indicate that the omental metastases mediated by Jagged2-expressing ovarian cancer cells are dependent on coordinated mesothelial-stromal Notch activation and that this pathway may be pharmacologically inhibited to prevent these metastases from occurring in the omental milieu.